Role of first trimester HbA1c as a predictor of adverse obstetric outcomes in a multi-ethnic cohort.
Author(s) -
Laura Mañé,
Juana A. FloresLe Roux,
David Benaiges,
Marta Álvarez Rodríguez,
Irene Marcelo,
Juan J. Chillarón,
Juan PedroBotet,
Gemma Llauradó,
Lucía Gortazar,
Ramón Carreras,
Antonio Payà
Publication year - 2016
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2016-2581
Subject(s) - medicine , obstetrics , pregnancy , gestational diabetes , preeclampsia , confidence interval , cohort study , prospective cohort study , population , diabetes mellitus , gestation , cohort , endocrinology , genetics , environmental health , biology
Risk of obstetric complications increases linearly with rising maternal glycemia. Testing hemoglobin A1c (HbA1c) is an effective option to detect hyperglycemia, but its association with adverse pregnancy outcomes remains unclear. Emerging data sustain that an early HbA1c ≥5.9% could act as a pregnancy risk marker.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom